Bacil Pharma Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported revenue was INR 0.288 million compared to INR 0.388 million a year ago. Net loss was INR 0.115 million compared to INR 0.037 million a year ago. Basic loss per share from continuing operations was INR 0.02 compared to INR 0.01 a year ago. Diluted loss per share from continuing operations was INR 0.02 compared to INR 0.01 a year ago.
For the six months, revenue was INR 0.764 million compared to INR 1.04 million a year ago. Net income was INR 0.059 million compared to INR 0.187 million a year ago. Basic earnings per share from continuing operations was INR 0.01 compared to INR 0.03 a year ago. Diluted earnings per share from continuing operations was INR 0.01 compared to INR 0.03 a year ago.